A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.
Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device.
Yavapai County will be part of the High Intensity Drug Trafficking Area program, which opens up federal resources to police ...
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
The FDA released its annual Pesticide Residue Monitoring Program Report for Fiscal Year 2022, summarizing findings from the ...
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive ...
The federal 340B Drug Pricing Program was designed to encourage hospitals and clinics to provide low-income patients with ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
A no vote on Prop 34. is a vote to keep rules governing California-based participants in the federal drug discount program ...